Firefly Neuroscience Reports 20-Fold Commercial Footprint Expansion and 33-Fold Increase in EEG/ERP Scan Volumes

Reuters
03/04
<a href="https://laohu8.com/S/AIFF">Firefly Neuroscience</a> Reports 20-Fold Commercial Footprint Expansion and 33-Fold Increase in EEG/ERP Scan Volumes

Firefly Neuroscience Inc. reported a greater than 20-fold expansion of its commercial footprint and a 33-fold increase in EEG/ERP brain scan volumes. The company said that by the end of 2025 it had 99 commercial users who completed more than 10,800 EEG/ERP brain scans, following its acquisition of Evoke Neuroscience, Inc. Firefly also reported that partner sites and EEG/ERP clinical assessments increased 1,880% and 3,227%, respectively, compared with the end of 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040745PRIMZONEFULLFEED9665671) on March 04, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10